Results 121 to 130 of about 23,834 (214)

Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in BRCA1/2-proficient ovarian cancer. [PDF]

open access: yesPLoS One
Deng O   +9 more
europepmc   +1 more source

Stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6: hereditary cancer syndrome?

open access: yes
We present the case of a 69-year-old male diagnosed with stage IV perihilar cholangiocarcinoma with loss of expression of MSH2 and MSH6 proteins, but somatic wild type MSH2 and MSH6 genes with Oncomine Comprehensive Assay (OCA) genomic sequencing panel ...
Gutiérrez Pérez, César   +6 more
core   +1 more source

Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy. [PDF]

open access: yesJ Clin Invest
Moisoiu V   +15 more
europepmc   +1 more source

An update on APC I1307K homozygosity: observations from a large multigene panel testing cohort. [PDF]

open access: yesFam Cancer
Zaretsky L   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy